These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11518421)

  • 1. Treatment of partial seizures and seizure-like activity with felbamate in six dogs.
    Ruehlmann D; Podell M; March P
    J Small Anim Pract; 2001 Aug; 42(8):403-8. PubMed ID: 11518421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate as an oral add-on therapy in six dogs with presumptive idiopathic epilepsy and generalized seizures resistant to drug therapy.
    Dewey CW; Rishniw M; Sakovitch K
    Open Vet J; 2022; 12(4):445-450. PubMed ID: 36118733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic drug therapy.
    Podell M
    Clin Tech Small Anim Pract; 1998 Aug; 13(3):185-92. PubMed ID: 9775509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
    Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felbamate for partial seizures: results of a controlled clinical trial.
    Leppik IE; Dreifuss FE; Pledger GW; Graves NM; Santilli N; Drury I; Tsay JY; Jacobs MP; Bertram E; Cereghino JJ
    Neurology; 1991 Nov; 41(11):1785-9. PubMed ID: 1944909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felbamate as an add-on therapy for refractory epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008295. PubMed ID: 21249704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures.
    Bourgeois B; Leppik IE; Sackellares JC; Laxer K; Lesser R; Messenheimer JA; Kramer LD; Kamin M; Rosenberg A
    Neurology; 1993 Apr; 43(4):693-6. PubMed ID: 8469324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review.
    Grosso S; Cordelli DM; Coppola G; Franzoni E; Verrotti A; Berardi R; Balestri P
    Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate in the treatment of acquired epileptic aphasia.
    Glauser TA; Olberding LS; Titanic MK; Piccirillo DM
    Epilepsy Res; 1995 Jan; 20(1):85-9. PubMed ID: 7713063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felbamate pharmacology and use in epilepsy.
    Burdette DE; Sackellares JC
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Felbamate monotherapy for partial-onset seizures: an active-control trial.
    Faught E; Sachdeo RC; Remler MP; Chayasirisobhon S; Iragui-Madoz VJ; Ramsay RE; Sutula TP; Kanner A; Harner RN; Kuzniecky R
    Neurology; 1993 Apr; 43(4):688-92. PubMed ID: 8469323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures.
    Devinsky O; Faught RE; Wilder BJ; Kanner AM; Kamin M; Kramer LD; Rosenberg A
    Epilepsy Res; 1995 Mar; 20(3):241-6. PubMed ID: 7796796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial.
    Dodson WE
    Epilepsia; 1993; 34 Suppl 7():S18-24. PubMed ID: 8243374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of felbamate in the treatment of intractable pediatric epilepsy.
    Zupanc ML; Roell Werner R; Schwabe MS; O'Connor SE; Marcuccilli CJ; Hecox KE; Chico MS; Eggener KA
    Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased seizure frequency associated with felbamate withdrawal in adults.
    Welty TE; Privitera M; Shukla R
    Arch Neurol; 1998 May; 55(5):641-5. PubMed ID: 9605720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome
    N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate: a new antiepileptic drug.
    Wagner ML
    Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats.
    Borowicz KK; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Pharmacol Biochem Behav; 2004 May; 78(1):103-10. PubMed ID: 15159139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.